Drug Type Toxin |
Synonyms Botulinum toxin A topical, ANT 1207, ANT-1207 |
Target |
Action inhibitors |
Mechanism SNAP25 inhibitors(Synaptosomal-associated protein 25 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Botulinum toxin A(Anterios, Inc.) | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Primary Axilary Hyperhidrosis | Phase 2 | United States | 03 Jun 2015 | |
Crow's feet | Phase 2 | United States | 01 May 2011 | |
Lateral Canthal Lines | Phase 2 | United States | 01 May 2011 | |
Acne Vulgaris | Phase 2 | United States | 01 Jan 2011 |
Phase 2 | 145 | Vehicle (Vehicle) | pfyarrmdyt = qnesrncnms cnmzdtkomv (hddeundpgg, rgeclamrtg - qihhkfghpp) View more | - | 20 Sep 2017 | ||
(ANT-1207 Dose 1) | pfyarrmdyt = qhhfffvhrr cnmzdtkomv (hddeundpgg, rskfquxqzc - wcchkdxbaz) View more |